Russian President Vladimir Putin said Wednesday that a second coronavirus vaccine has been granted regulatory approval.
Putin said the vaccine, EpiVakKorona, was registered at the Vector State Research Center in Novosibirsk.
On Aug. 11, Russia issued a temporary conditional registration for a vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
Conditional registration is issued for medicine considered vital to protect public health in an emergency such as the coronavirus pandemic.
Anadolu Agency website contains only a portion of the news stories offered to subscribers in the AA News Broadcasting System (HAS), and in summarized form. Please contact us for subscription options.